“University scientists studying Remune last year accused Immune Response of trying to stop publication of a failed Remune clinical trial, and the Food and Drug Administration warned the company in 1995 not to manipulate data to show positive findings.”

Immunization Newsbriefs © Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii’s new website at http://www.immunizationinfo.org.

July 9, 2001

“”Lack of Financing May End Trial of an AIDS Vaccine”

New York Times (www.nytimes.com) (07/09/01) P. C2; Pollack,Andrew

Pfizer, which has already paid Immune Response $47 million to put the candidate HIV vaccine Remune through clinical trials, says it has pulled its support of the drug because Immune Response has failed to show that Remune is effective in delaying the onset of AIDS.  Jonas Salk, the inventor of the polio vaccine, also invented Remune, a killed virus vaccine just like the one for polio.  University scientists studying Remune last year accused Immune Response of trying to stop publication of a failed Remune clinical trial, and the Food and Drug Administration warned the company in 1995 not to manipulate data to show positive findings.  With only $12 million in cash, Immune is uncertain how to fund continued clinical trials of Remune.

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.